PHS

PFM Health Sciences Portfolio holdings

AUM $1.15B
1-Year Est. Return 21.39%
This Quarter Est. Return
1 Year Est. Return
+21.39%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.15B
AUM Growth
-$149M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1
+$20.8M
2
+$17.1M
3
+$16M
4
MASI icon
Masimo
MASI
+$15.9M
5
AKRO icon
Akero Therapeutics
AKRO
+$14.2M

Top Sells

1
+$61.6M
2
+$54M
3
+$38.4M
4
ARGX icon
argenx
ARGX
+$34M
5
UHS icon
Universal Health Services
UHS
+$29.2M

Sector Composition

1 Healthcare 96.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ERAS icon
51
Erasca
ERAS
$644M
$1.36M 0.12%
1,072,224
-2,417,335
GPCR icon
52
Structure Therapeutics
GPCR
$1.54B
$1.17M 0.1%
56,594
+16,194
VKTX icon
53
Viking Therapeutics
VKTX
$3.53B
$1,000K 0.09%
+37,729
SGMT icon
54
Sagimet Biosciences
SGMT
$242M
$686K 0.06%
90,000
-559,006
HOWL icon
55
Werewolf Therapeutics
HOWL
$72.7M
$437K 0.04%
401,110
-2,105,410
XRT icon
56
SPDR S&P Retail ETF
XRT
$607M
– –
-36,471
ACLX icon
57
Arcellx
ACLX
$4.62B
– –
-15,488
AZN icon
58
AstraZeneca
AZN
$259B
– –
-150,200
BDX icon
59
Becton Dickinson
BDX
$53.9B
– –
-91,571
BHVN icon
60
Biohaven
BHVN
$1.74B
– –
-197,307
CAPR icon
61
Capricor Therapeutics
CAPR
$285M
– –
-140,681
CELC icon
62
Celcuity
CELC
$2.97B
– –
-53,349
CNC icon
63
Centene
CNC
$17.7B
– –
-135,398
ELV icon
64
Elevance Health
ELV
$77.7B
– –
-88,222
IOVA icon
65
Iovance Biotherapeutics
IOVA
$778M
– –
-132,152
IQV icon
66
IQVIA
IQV
$37B
– –
-111,854
KROS icon
67
Keros Therapeutics
KROS
$474M
– –
-104,323
PMVP icon
68
PMV Pharmaceuticals
PMVP
$81.6M
– –
-3,301,942
SNDX icon
69
Syndax Pharmaceuticals
SNDX
$1.3B
– –
-926,424
SRPT icon
70
Sarepta Therapeutics
SRPT
$2.35B
– –
-50,809
SWTX
71
DELISTED
SpringWorks Therapeutics
SWTX
– –
-26,437
TMO icon
72
Thermo Fisher Scientific
TMO
$214B
– –
-21,897
TSBX
73
DELISTED
Turnstone Biologics
TSBX
– –
-932,348
UHS icon
74
Universal Health Services
UHS
$13.4B
– –
-155,520
VERV
75
DELISTED
Verve Therapeutics
VERV
– –
-155,495
1 2
3
4